Adaptive Biotechnologies
ADPT
ADPT
117 hedge funds and large institutions have $2.5B invested in Adaptive Biotechnologies in 2019 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
117
Holders Change
+6
Holders Change %
+5.41%
% of All Funds
2.57%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
51
Increased
31
Reduced
25
Closed
45
Calls
$4.78M
Puts
$3.02M
Net Calls
+$1.76M
Net Calls Change
+$1.76M
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$46.2M |
| 2 |
2
BlackRock
New York
|
$58.6M |
| 3 |
TM
3
Tiger Management
New York
|
$34.5M |
| 4 |
TCM
4
TimesSquare Capital Management
New York
|
$34.1M |
| 5 |
FAM
5
Fred Alger Management
New York
|
$33.9M |
